<p><b>TABLE OF INTERACTIONS WITH</b></p>

<p><b>TRIMETHOPRIM</b></p>

<p><b>See also: hyperkalemia inducing medications</b></p>

<p><b>From the French ANSM drug interactions document of September 2016, p. 222</b></p>

<table cellspacing="0" cellpadding="0" border="1">
<tbody>
<tr>
<td valign="top"><p><b>TRIMETHOPRIM</b></p>

<p><b>RxNorm: 10829</b></p>

<p><b>ATC: J01EA01</b></p></td>
<td valign="top"><p><b>CICLOSPORIN</b></p>

<p><b>RxNorm: 3008 </b></p>

<p><b>ATC: </b></p>

<p><b>L04AD01 S01XA18</b></p></td>
<td valign="top"><p>With the trimethoprim (alone or in combination) by oral route: increase of the creatinemia with possible decrease of the blood concentrations of ciclosporin</p>

<p>With trimethoprime (alone or in combination) by IV route: the decrease of the blood concentrations of ciclosporin can be very large with possible loss of all immunosuppressant capacity</p></td>
<td valign="top"><p><b>Take into account</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>TRIMETHOPRIM</b></p>

<p><b>RxNorm: 10829</b></p>

<p><b>ATC: J01EA01</b></p></td>
<td valign="top"><p><b>METHOTREXATE</b></p>

<p><b>RxNorm: 6851 </b></p>

<p><b>ATC: </b></p>

<p><b>L01BA01 L04AX03</b></p></td>
<td valign="top"><p>Increase of the hematological toxicity of the methotrexate (decrease of its renal excretion as well as inhibition of the dihydrofolate reductase).</p></td>
<td valign="top"><p><b>CONTRAINDICATION</b></p>

</td>
</tr>

<tr>
<td valign="top"><p><b>TRIMETHOPRIM</b></p>

<p><b>RxNorm: 10829</b></p>

<p><b>ATC: J01EA01</b></p></td>
<td valign="top"><p><b>PYRIMETHAMINE</b></p>

<p><b>RxNorm: 9010</b></p>

<p><b>ATC:</b></p>

<p><b>P01BD01 P01BF04 </b></p></td>
<td valign="top"><p>Megaloblastic anemia, more particularly with strong doses of the two products (deficit of folic acid due to the combination of the two 2-4 diaminopyrimidines)</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Regular CBC and addition of a treatment with folic acid (regular IM injections<b>). </b></p></td>
</tr>

<tr>
<td valign="top"><p><b>TRIMETHOPRIM</b></p>

<p><b>RxNorm: 10829</b></p>

<p><b>ATC: J01EA01</b></p></td>
<td valign="top"><p><b>REPAGLINIDE</b></p>

<p><b>RxNorm: 73044</b></p>

<p><b>ATC: A10BX02</b></p></td>
<td valign="top"><p>Risk of increase of the plasma concentrations of repaglinide due to inhibition of its hepatic metabolism by the trimethoprim</p></td>
<td valign="top"><p><b>Not recommended</b></p>

<p>If administering these medications together cannot be avoided, strict clinical and biological monitoring. </p></td>
</tr>

</tbody>
</table>

